Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Corvus Pharmaceuticals, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Utah
Dizal Pharmaceuticals
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.
Mayo Clinic
University of Utah
University of Michigan Rogel Cancer Center
Emory University
Acrotech Biopharma Inc.
Spectrum Pharmaceuticals, Inc
University of Utah
Herlev Hospital
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.
Acrotech Biopharma Inc.
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Arizona
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Holy Cross Hospital, Florida
Yale University
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Virginia Commonwealth University
National Institutes of Health Clinical Center (CC)
Spectrum Pharmaceuticals, Inc
Valerio Therapeutics
Valerio Therapeutics
Valerio Therapeutics
Valerio Therapeutics
Valerio Therapeutics
Valerio Therapeutics
Valerio Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)